Learn More
Medchemexpress LLC AGX51 | 330834-54-3 | 99.3% | 431.52 | 5 MG

Supplier: Medchemexpress LLC 5MGHY129241
AGX51 is a first-in-class pan-Id (inhibitors of DNA-binding/differentiation proteins) antagonist and degrader, primarily used in cancer research. It functions by inhibiting Id1-E47 interaction, leading to ubiquitin-mediated degradation of Ids. This action results in cell growth arrest and a reduction in cell viability, demonstrating an ability to inhibit Triple-Negative Breast Cancer (TNBC) with an IC50 of approximately 25 nM.
- First-in-class pan-Id antagonist and degrader
- Inhibits Id1-E47 interaction
- Leads to ubiquitin-mediated degradation of Ids
- Results in cell growth arrest and viability reduction
- Effective in inhibiting Triple-Negative Breast Cancer (TNBC)
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.